Arteris (NASDAQ:AIP) Price Target Cut to $40.00 by Analysts at Jefferies Financial Group

Arteris (NASDAQ:AIP) had its target price lowered by Jefferies Financial Group from $50.00 to $40.00 in a report published on Friday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock.

Several other equities research analysts also recently weighed in on AIP. Rosenblatt Securities reiterated a “buy” rating and issued a $38.00 price target on shares of Arteris in a report on Friday, August 7th. Oppenheimer initiated coverage on Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 target price for the company. Roth Capital started coverage on Arteris in a report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 target price for the company. Weiss Ratings raised Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Finally, Craig Hallum began coverage on Arteris in a research note on Monday, September 21st. They set a “buy” rating and a $30.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $35.86.

Arteris Trading Up 11.7%

AIP traded up $1.87 on Friday, hitting $17.80. The company had a trading volume of 1,430,681 shares, compared to its average volume of 581,883. The company has a market cap of $874.87 million, a PE ratio of -20.00 and a beta of 1.93. Arteris has a 12-month low of $12.06 and a 12-month high of $50.26. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The business’s fifty day simple moving average is $21.39 and its 200 day simple moving average is $24.94.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Thursday, November 5th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. The company had revenue of $25.77 million for the quarter, compared to analysts’ expectations of $24.57 million. Equities research analysts expect that Arteris will post -0.68 EPS for the current year.

Insider Activity

In related news, CEO K Janac sold 100,000 shares of Arteris stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $23.82, for a total transaction of $2,382,000.00. Following the transaction, the chief executive officer directly owned 8,129,071 shares of the company’s stock, valued at $193,634,471.22. This trade represents a 1.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, VP Paul Alpern sold 6,500 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $23.84, for a total transaction of $154,960.00. Following the completion of the transaction, the vice president directly owned 70,733 shares of the company’s stock, valued at $1,686,274.72. This trade represents a 8.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 478,631 shares of company stock valued at $10,823,565. 23.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Aberdeen Group plc bought a new stake in Arteris during the third quarter valued at about $7,541,000. Russell Investments Group Ltd. grew its stake in Arteris by 9.5% in the third quarter. Russell Investments Group Ltd. now owns 177,398 shares of the company’s stock valued at $4,161,000 after purchasing an additional 15,349 shares during the last quarter. AlphaCore Capital LLC raised its holdings in Arteris by 7.5% in the third quarter. AlphaCore Capital LLC now owns 10,362 shares of the company’s stock worth $245,000 after purchasing an additional 720 shares in the last quarter. Fulcrum Asset Management LLP bought a new position in Arteris in the third quarter worth about $400,000. Finally, CenterBook Partners LP purchased a new stake in shares of Arteris during the third quarter valued at about $4,632,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported Q3 revenue of $25.8 million, above the roughly $24.6 million consensus estimate. Its loss of $0.02 per share was narrower than analysts expected and improved from a $0.09 loss a year earlier. Arteris Q3 results and guidance
• Positive Sentiment: The company forecast Q4 revenue of $25.7 million to $26.7 million and FY2026 revenue of $98.5 million to $99.5 million. It also set a $103 million to $107 million target for annual contract value plus royalties, offering investors visibility into expected business activity. Arteris FY2026 forecast
• Positive Sentiment: Arteris surpassed 1,000 customer chip-design starts. The company says AI accounted for about half of its recent projects, pointing to potential demand from a fast-growing market. Arteris surpasses 1,000 customer design starts
• Negative Sentiment: Despite the improvement and estimate beat, Arteris remains loss-making, so investors may continue to watch its path toward profitability. Arteris Q3 loss and revenue results

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.

The company’s portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.